Gene therapy studies using adenoviral and retroviral delivery systems in tumors have demonstrated a role for TIMP-2 in suppressing angiogenesis and subsequent tumor progression in animal models [10], [11]. The gene discussed is TIMP2; the disease is neoplasm.